• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION EXACTA-MIX 2400 COMPOUNDING SYSTEM; SYSTEM / DEVICE, PHARMACY COMPOUNDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION EXACTA-MIX 2400 COMPOUNDING SYSTEM; SYSTEM / DEVICE, PHARMACY COMPOUNDING Back to Search Results
Model Number EM2400
Device Problems Contamination (1120); Corroded (1131); Nonstandard Device (1420)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/09/2022
Event Type  malfunction  
Event Description
Exacta-mix 2400 compounding system, cleaned according to usp(united states pharmacopeia) standards and manufacturer guidelines, was found to have corrosion on the stainless steel vial rack of the fda 510k approved devices (k002705) due to a defect in manufacturer design.The corrosion led to a voluntary recall, as the vial rack resides in the iso(international standards organization) 5 primary engineering control, and in the direct path of first air reaching critical sites on sterile medication ingredients.The manufacturer design was identified by a metal stripping company that evaluated the vial racks and determined that the stainless steel utilized is a 306 grade stainless steel, not a 316 or 320 grade resistant to corrosion.The corrosion is a result of bimetallic corrosion, due to the stainless steel of the rods coming in contact with aluminum of the vial rack connections and the clips used for the vials.When these two metals come together in the presence of a corrosive cleaning agent such as quaternary ammoniums, it leads to corrosion due to the design of the vial rack.The corrosion was confirmed as it was examined under a microscope for evaluation.According to fda guidance document, insanitary conditions at compounding facilities guidance for industry (docket number: (b)(4) section iii.A.1, foreign matter in the production area (ie.Rust) is considered insanitary and subject to fda 483 observations.The design of the 510k device, along with cleaning guidelines within usp standards and manufacturer recommendations, leads to an increased risk of insanitary conditions that may impact the sterility of compounded admixtures.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXACTA-MIX 2400 COMPOUNDING SYSTEM
Type of Device
SYSTEM / DEVICE, PHARMACY COMPOUNDING
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
MDR Report Key16454185
MDR Text Key310586206
Report NumberMW5115293
Device Sequence Number1
Product Code NEP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 02/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberEM2400
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/27/2023
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-